Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Test Type
3.2. Snippet by Molecule Type
3.3. Snippet by End Users
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing expenditure on bioanalytical services
4.1.2. Restraints
4.1.2.1. Challenges in the bioanalytical development method
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Test Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
7.1.2. Market Attractiveness Index, By Test Type
7.2. Pharmacokinetic (PK) Testing *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Pharmacodynamics (PD) Testing
7.4. ADME Testing
7.4.1. In-Vivo ADME
7.4.2. In-Vitro ADME
7.5. Bioavailability Testing
7.6. Bioequivalence Testing
7.7. Others
8. By Molecule Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Molecule Type
8.1.2. Market Attractiveness Index, By Molecule Type
8.2. Small Molecule*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Large Molecule
8.3.1. Immunoassays
8.3.2. LC-MS Studies
8.3.3. Others
9. By End Users
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
9.1.2. Market Attractiveness Index, By End Users
9.2. Biopharmaceutical Companies *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinical Research Organizations
9.4. Contract Development and Manufacturing Organization (CDMO)
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Molecule Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Introduction
10.3.3. Key Region-Specific Dynamics
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Molecule Type
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. UK
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Molecule Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Molecule Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Molecule Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Syneous Health
12.1.1. Company Overview
12.1.2. Diagnostic technique Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. SGS S.A
12.3. ICON Plc
12.4. Charles River Laboratories Inc.
12.5. Laboratory Corporation of America Holdings
12.6. Intertek Group Plc.
12.7. Q2 Solutions
12.8. Pace Analytical Services LLC
12.9. Prolytix
12.10. Frontage Laboratories
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us